Learn how Zero-Knowledge Proofs (ZKP) provide verifiable tool execution for Model Context Protocol (MCP) in a post-quantum world. Secure your AI infrastructure today.

Recursion Pharmaceuticals (RXRX) shares recently closed at US$3.98, with the stock showing a negative return over the past month and past 3 months, which may prompt investors to reassess its current ...

People who interact with chatbots for emotional support or other personal reasons are likelier to report symptoms of depression or anxiety, a new study finds. The researchers from Mass General Brigham ...

She needed a moo-sage. Utilizing implements isn’t limited to primates and brainiac birds. A brown cow named Veronika was documented using tools with impressive skill for the first time ever, ...

PCWorld reports that Microsoft’s Copilot AI holds only 1.1% of the web AI market share, declining from 1.5% over the past year. ChatGPT dominates with 64.5% market share while Google’s Gemini has ...

AI on the JVM accelerates: New frameworks like Embabel, Koog, Spring AI, and LangChain4j drive rapid adoption of AI-native and AI-assisted development in Java. Java 25 anchors a modern baseline: The ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

Monday - Friday, 6:00 - 7:00 PM ET It's that time again! "Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.

This is this week’s ForbesWomen newsletter, which every Thursday brings news about the world’s top female entrepreneurs, leaders and investors straight to your inbox. Click here to get on the ...

Your favorite latte at the local coffee shop could soon cost $5, $5.10 or $5.25—depending on how you pay. A settlement between Visa, Mastercard and U.S. merchants announced this week could usher in a ...

Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...